China SXT Pharmaceuticals share price logo

China SXT Pharmaceuticals

NASDAQ: SXTC

$5.10

+1.35

(+36.01%)

as on

China SXT Pharmaceuticals Stock Performance

as on August 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.20
    $5.55
    downward going graph

    17.65%

    Downside

    8.82%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.10
    $83,758.80
    downward going graph

    39.22%

    Downside

    1642229.41%

    Upside

    downward going graph

China SXT Pharmaceuticals share price movements today

Previous Close
$3.75
Open
$4.82
Volume
4.1M
Market Cap
$2.3M
Day's Low - High
$4.20 - $5.55
52 Week Low - High
$3.10 - $83,758.80

China SXT Pharmaceuticals Historical Returns

1 Month Return
-97.79 %
3 Month Return
-96.57 %
1 Year Return
-99.98 %
3 Year Return
-100 %
5 Year Return
-100 %

China SXT Pharmaceuticals Stock Fundamentals & Key Indicators

Check China SXT Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.3M

EPS (TTM)

-7.95

Dividend Yield

0.00%

PE Ratio (TTM)

-0.39

Industry PE ratio

0

PEG Ratio

0.0001932378991404386

Return On Equity TTM

-31.02%

China SXT Pharmaceuticals Stock Valuation

Track how China SXT Pharmaceuticals P/E has moved over time to understand its valuation trends.

China SXT Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-3659.95x)

March 31, 2025

Industry (0.00x)

March 31, 2026

Today (-14.72x)

March 31, 2026

Highest (-2.55x)

March 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -14.72x

China SXT Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of China SXT Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
China SXT Pharmaceuticals image
China SXT Pharmaceuticals
NA$2.3M-100%-0.3944.37%NA
United Therapeutics image
United Therapeutics
BUY$21.4B145.28%16.5886.14%NA
Viatris image
Viatris
HOLD$18.6B9.88%-44.5634.83%2.9899999999999998%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$42.7BNA19.814.55%126.42999999999999%
Zoetis image
Zoetis
BUY$30.5B-64.28%12.4770.87%2.76%
See all

Stock Returns calculator for China SXT Pharmaceuticals Stock including INR - Dollar returns

The China SXT Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

China SXT Pharmaceuticals investment value today

Current value as on today

₹29

Returns

-₹99,971

(-99.97%)

Returns from China SXT Pharmaceuticals Stock

-₹99,973 (-99.97%)

Dollar Impact

₹3 (+0.00%)

Indian Investors' Interest in China SXT Pharmaceuticals Stock

Investment in China SXT Pharmaceuticals Shares on INDmoney has grown by 4190.90% in the last 30 days, indicating increased investment activity.

Time period: to

Change:4190.90% versus previous 30 day period

Search interest for China SXT Pharmaceuticals Stock has increased by 902% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:902% versus previous 30 day period

China SXT Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
4
0
0
0
0
0
0
1
Gross Profit
0
0
4
0
0
0
0
0
0
0
Operating Income
-4
3
0
0
0
-1
-1
-6
0
0
EBITDA
-4
3
0
0
0
-1
-1
-6
0
0
Interest Expense
0
0
0
0
0
0
0
0
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
2
-7
0
0
-1
-1
-6
0
-1
Income Tax Expense
4
0
-10
-
-
-
-
-
-
-1
Net Income
-4
3
3
0
0
-1
-1
-6
0
0
Net Profit Margin
19.75%
26.86%
26.86%
16.25%
16.25%
25.53%
25.53%
16.23%
28.74%
69.59%

China SXT Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
4
7
7
5
4
2
1
1
1
1
Gross Profit
2
3
4
2
2
1
0
0
0
0
Operating Income
1
1
1
-1
-2
-5
-5
-2
-2
-7
EBITDA
1
1
1
-1
-1
-5
-5
-2
-2
-6
Interest Expense
0
0
0
3
1
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
1
1
1
-10
-2
-5
-5
-3
-3
-6
Income Tax Expense
0
0
0
0
0
0
-
-
-
0
Net Income
1
1
1
-10
-2
-5
-5
-3
-3
-6
Net Profit Margin
47.36%
48.46%
65.77%
52.37%
59.43%
48.10%
21.62%
28.73%
21.11%
17.09%

China SXT Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-4
3
3
0
0
-1
-2
-6
0
0
Operating Cash Flow
0
0
0
0
0
0
0
-1
-1
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-2
0
0
3
3
0
1
5
4
9
Change in Cash
-2
0
0
3
3
0
0
3
3
6

China SXT Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
1
1
1
-7
-2
-5
-5
-3
-3
-6
Operating Cash Flow
0
1
0
0
-1
-2
0
-1
-2
-4
Investing Cash Flow
0
-1
0
-5
-5
0
0
0
0
-1
Financing Cash Flow
0
0
9
3
12
1
2
-2
8
14
Change in Cash
0
0
8
-2
6
0
1
-5
6
10

Mutual Funds that own China SXT Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in China SXT Pharmaceuticals.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.026943%
356

Global Institutional Holdings in China SXT Pharmaceuticals

Funds
Holdings
Amvescap Plc.
0%
Virtu Financial LLC
0.03%
Acadian Asset Management LLC
0%
Bank of Montreal
0%
Geode Capital Management, LLC
0%
See all

Insights on China SXT Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 255.74K → 1.19M (in $), with an average increase of 78.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SXTC stock has moved up by 6.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -6.36M → 163.71K (in $), with an average increase of 3965.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 121.3% return, outperforming this stock by 221.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation Common Stock has given 61.9% return, outperforming this stock by 161.9%

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
OrganisationChina SXT Pharmaceuticals
Headquarters178 Taidong Road North, Taizhou, China, 225300
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Feng Zhou
E-voting on sharesClick here to vote

Key Management of China SXT Pharmaceuticals

Name

Title

Mr. Feng Zhou

Chairman of the Board & Co-CEO

Mr. Sze Beng Lim

Co-Chief Executive Officer

Mr. Xiaodong Pan

Chief Financial Officer

Mr. Jun Zheng

Executive Director

FAQs

What is China SXT Pharmaceuticals share price today?

China SXT Pharmaceuticals share price today is $5.10 as on at the close of the market. China SXT Pharmaceuticals share today touched a day high of $5.55 and a low of $4.20.

What is the 52 week high and 52 week low for China SXT Pharmaceuticals share?

China SXT Pharmaceuticals share touched a 52 week high of $83,758.80 on and a 52 week low of $3.10 on . China SXT Pharmaceuticals stock price today i.e. is closed at $5.10,which is 99.99% down from its 52 week high and 64.52% up from its 52 week low.

What is China SXT Pharmaceuticals's market capitalisation today?

China SXT Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in China SXT Pharmaceuticals Stock (SXTC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for China SXT Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in China SXT Pharmaceuticals Shares that will get you 0.2941 shares as per China SXT Pharmaceuticals share price of $5.10 per share as on August 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy China SXT Pharmaceuticals Stock (SXTC) from India?

Indian investors can start investing in China SXT Pharmaceuticals (SXTC) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in China SXT Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on China SXT Pharmaceuticals share’s latest price of $5.10 as on August 19, 2026 at 1:29 am IST, you will get 1.9608 shares of China SXT Pharmaceuticals. Learn more about fractional shares .

What are the returns that China SXT Pharmaceuticals has given to Indian investors in the last 5 years?

China SXT Pharmaceuticals stock has given -100% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?